SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-23-053063
Filing Date
2023-04-28
Accepted
2023-04-28 16:31:30
Documents
17
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm233588d2_10ka.htm   iXBRL 10-K/A 370567
2 EXHIBIT 31.1 tm233588d2_ex31-1.htm EX-31.1 3710
3 EXHIBIT 31.2 tm233588d2_ex31-2.htm EX-31.2 3493
8 GRAPHIC tm233588d2_10ka-img001.gif GRAPHIC 19544
9 GRAPHIC tm233588d2_10ka-img002.gif GRAPHIC 17813
  Complete submission text file 0001104659-23-053063.txt   794407

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA jagx-20221231.xsd EX-101.SCH 3563
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jagx-20221231_def.xml EX-101.DEF 28677
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20221231_lab.xml EX-101.LAB 38858
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20221231_pre.xml EX-101.PRE 27287
11 EXTRACTED XBRL INSTANCE DOCUMENT tm233588d2_10ka_htm.xml XML 6631
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36714 | Film No.: 23867076
SIC: 2834 Pharmaceutical Preparations